DE1203913B - Verfahren zur Herstellung von hochmolekularen arzneilichen Wirkstoffen aus apathogenen Anaerobierkulturen - Google Patents

Verfahren zur Herstellung von hochmolekularen arzneilichen Wirkstoffen aus apathogenen Anaerobierkulturen

Info

Publication number
DE1203913B
DE1203913B DEF40829A DEF0040829A DE1203913B DE 1203913 B DE1203913 B DE 1203913B DE F40829 A DEF40829 A DE F40829A DE F0040829 A DEF0040829 A DE F0040829A DE 1203913 B DE1203913 B DE 1203913B
Authority
DE
Germany
Prior art keywords
molecular weight
high molecular
culture
substances
clostridium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEF40829A
Other languages
German (de)
English (en)
Inventor
Dipl-Chem Dr Heinz Feier
Dr Dietmar Gericke
Dr Georg Nesemann
Dr Paul Praeve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE664163D priority Critical patent/BE664163A/xx
Application filed by Hoechst AG filed Critical Hoechst AG
Priority to DEF40829A priority patent/DE1203913B/de
Priority to US398088A priority patent/US3303096A/en
Priority to DK470664AA priority patent/DK106933C/da
Priority to FR1554555D priority patent/FR1554555A/fr
Priority to GB39263/64A priority patent/GB1071717A/en
Publication of DE1203913B publication Critical patent/DE1203913B/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/145—Clostridium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/842—Clostridium

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DEF40829A 1963-09-25 1963-09-25 Verfahren zur Herstellung von hochmolekularen arzneilichen Wirkstoffen aus apathogenen Anaerobierkulturen Pending DE1203913B (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
BE664163D BE664163A (https=) 1963-09-25
DEF40829A DE1203913B (de) 1963-09-25 1963-09-25 Verfahren zur Herstellung von hochmolekularen arzneilichen Wirkstoffen aus apathogenen Anaerobierkulturen
US398088A US3303096A (en) 1963-09-25 1964-09-21 Process for preparing high molecular weight products of apathogenic anaerobic cultures
DK470664AA DK106933C (da) 1963-09-25 1964-09-24 Fremgangsmåde til fremstilling af højmolekylære produkter, som forøger den ikke-specifikke resistens af den dyriske og menneskelige organisme, ud fra kulturfiltrater af ikke-patogene, anaerobe bakterier.
FR1554555D FR1554555A (https=) 1963-09-25 1964-09-25
GB39263/64A GB1071717A (en) 1963-09-25 1964-09-25 Process for preparing high molecular weight products from apathogenic anaerobe cultures

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEF40829A DE1203913B (de) 1963-09-25 1963-09-25 Verfahren zur Herstellung von hochmolekularen arzneilichen Wirkstoffen aus apathogenen Anaerobierkulturen

Publications (1)

Publication Number Publication Date
DE1203913B true DE1203913B (de) 1965-10-28

Family

ID=7098407

Family Applications (1)

Application Number Title Priority Date Filing Date
DEF40829A Pending DE1203913B (de) 1963-09-25 1963-09-25 Verfahren zur Herstellung von hochmolekularen arzneilichen Wirkstoffen aus apathogenen Anaerobierkulturen

Country Status (6)

Country Link
US (1) US3303096A (https=)
BE (1) BE664163A (https=)
DE (1) DE1203913B (https=)
DK (1) DK106933C (https=)
FR (1) FR1554555A (https=)
GB (1) GB1071717A (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3119741A (en) * 1962-04-10 1964-01-28 Princeton Lab Inc Non-specific immunizing agent
NL299109A (https=) * 1962-11-05

Also Published As

Publication number Publication date
GB1071717A (en) 1967-06-14
DK106933C (da) 1967-04-03
BE664163A (https=)
US3303096A (en) 1967-02-07
FR1554555A (https=) 1969-01-24

Similar Documents

Publication Publication Date Title
EP0173241B1 (de) Vakzine zur Behandlung der Harnwegsinfektionen
DE2813353A1 (de) Substanz ks-2-a, verfahren zu deren herstellung und diese substanz enthaltendes mittel
DE2024586C3 (https=)
DE2457090C2 (de) Verfahren zur Herstellung von Impfstoffen sowie Antibronchialimpfstoff
DE69026371T2 (de) Heilmittel und verfahren zur inhibierung der vaskularisierung von tumoren
DE2518474A1 (de) Mitogenes mittel, verfahren zu seiner herstellung und diese mittel enthaltende arzneimittel und biologische reagenzien
DE4104728C2 (de) Verwendung eines Bakterien-Lysats zur Behandlung der atopischen Dermatitis
DE2262427C3 (de) Immunostimulierendes Mittel
CH657989A5 (de) Biologisch aktive substanz, verfahren zur herstellung der substanz, sowie die substanz enthaltende, immunoaktive zusammensetzung.
DE1203913B (de) Verfahren zur Herstellung von hochmolekularen arzneilichen Wirkstoffen aus apathogenen Anaerobierkulturen
EP0286869A1 (de) Verfahren zur Herstellung von Zellwandkomponenten aus Halobakterien und deren Verwendung als Arzneimittel
DE3118148A1 (de) Antiallergisches praeparat und verfahren zu seiner herstellung
Hegyeli et al. Preparation of retine from human urine
CH639133A5 (de) Verfahren zur herstellung einer antitumor wirksamen substanz mit immunostimulierender wirkung.
DE3817762C2 (https=)
DD232432A5 (de) Verfahren zur herstellung des wirkstoffes eines immunomodulator-medikamentes
DE2403733A1 (de) Neue lipopolysaccharide und verfahren zu ihrer herstellung
CH652028A5 (de) Extrakt aus pflanzen vom genus epimedium sp., verfahren zur herstellung dieses extrakts und verwendung des extrakts als wirksame komponente in einem immunstimulierenden mittel.
DE2146674C3 (de) Faktor und seine Verwendung als Arzneimittel
DE2445679B2 (de) Stimulierung der Immunität
DE3031152C2 (https=)
DE2326916A1 (de) Neue chemische substanz, genannt bredinin
AT87794B (de) Verfahren zur Herstellung fermenthaltiger Tiersera.
DE873732C (de) Verfahren zur Herstellung eines Heilmittels, insbesondere fuer Leber-, Gallen-, Magen- und Darmkrankheiten
AT234906B (de) Verfahren zur Herstellung eines neuen immunogenen Polysaccharids